A new, locally-produced COVID-19 vaccine will soon be available to the public in the UAE.
‘Hayat-Vax’ will be the first COVID-19 vaccine produced in the region that stems from the joint project between G42 in Abu Dhabi and Sinopharm in China.
RELATED STORY: China, UAE to expedite production of ‘affordable’ vaccines, establish mechanism to ease international travel, FM says
The word ‘Hayat’ means ‘Life’ in Arabic, and the ‘Hayat-Vax’ is the same Sinopharm vaccine that was registered by the UAE’s Ministry of Health and Prevention last December 2020.
G42 revealed that the production of ‘Hayat-Vax’ is already ongoing with its partner, Julphar – a pharmaceutical firm based in Ras Al Khaimah.
READ ON: UAE to launch first COVID-19 vaccine production line
The firm aims at a production capacity of at least two million doses per month.
Authorities state that the ‘Hayat-Vax’ will help boost the UAE’s vaccination campaign as it will soon be provided to the public through more 205 medical centers across all seven emirates.
